Imatinib and PTK787/ZK222584 in Refractory and/or Advanced Solid Tumors

Clinical trial NCT00611689 · COMPLETED

Trial details

NCT number: NCT00611689
Sponsor: SCRI Development Innovations, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Malignancy Solid Tumors

Start date: 2004-07-01
Primary completion: 2008-01-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.